Distinct systems for automatic and cognitively controlled time measurement: evidence from neuroimaging
… We include one study of our own which is not yet published, but currently under review (PA
Lewis, … (a,b) PA Lewis, RC Miall, unpublished data. 8 subjects indicated, via a button press, …
Lewis, … (a,b) PA Lewis, RC Miall, unpublished data. 8 subjects indicated, via a button press, …
Patterning self-assembled monolayers
RK Smith, PA Lewis, PS Weiss - Progress in surface science, 2004 - Elsevier
The understandings and applications of self-assembly have evolved significantly since the
adsorption of n-alkyldisulfides on gold surfaces was first reported. The desire to produce …
adsorption of n-alkyldisulfides on gold surfaces was first reported. The desire to produce …
Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences
Advances in the technologies and informatics used to generate and process large biological
data sets (omics data) are promoting a critical shift in the study of biomedical sciences. …
data sets (omics data) are promoting a critical shift in the study of biomedical sciences. …
Simulation of nonhomogeneous Poisson processes by thinning
PAW Lewis, GS Shedler - Naval research logistics quarterly, 1979 - Wiley Online Library
A simple and relatively efficient method for simulating one‐dimensional and two‐dimensional
nonhomogeneous Poisson processes is presented The method is applicable for any rate …
nonhomogeneous Poisson processes is presented The method is applicable for any rate …
Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with …
…, G Sharifova, JM Lund, A Tafur, PA Lewis… - JAMA internal …, 2021 - jamanetwork.com
Importance Hospitalized patients with COVID-19 are at risk for venous and arterial
thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is unknown. …
thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is unknown. …
Cystic fibrosis mortality and survival in the UK: 1947–2003
JA Dodge, PA Lewis, M Stanton… - European Respiratory …, 2007 - Eur Respiratory Soc
Data up to 1995 on the survival of 3-yr cohorts of patients with cystic fibrosis (CF) born in the
UK in the period 1968–1992 have previously been published. The present study reports …
UK in the period 1968–1992 have previously been published. The present study reports …
Overlapping memory replay during sleep builds cognitive schemata
PA Lewis, SJ Durrant - Trends in cognitive sciences, 2011 - cell.com
Sleep enhances integration across multiple stimuli, abstraction of general rules, insight into
hidden solutions and false memory formation. Newly learned information is better …
hidden solutions and false memory formation. Newly learned information is better …
[HTML][HTML] Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the …
…, KJ Heesom, M Zambon, J Ellis, PA Lewis… - Genome medicine, 2020 - Springer
Background SARS-CoV-2 is a recently emerged respiratory pathogen that has significantly
impacted global human health. We wanted to rapidly characterise the transcriptomic, …
impacted global human health. We wanted to rapidly characterise the transcriptomic, …
Brain activation patterns during measurement of sub-and supra-second intervals
… Author links open overlay panel PA Lewis a b , RC Miall b … ) and was therefore included
as part of the PMC in our review (Lewis & Miall, 2003). Although more data is needed to clarify …
as part of the PMC in our review (Lewis & Miall, 2003). Although more data is needed to clarify …
[HTML][HTML] Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
A major barrier to research on Parkinson's disease is inaccessibility of diseased tissue for
study. One solution is to derive induced pluripotent stem cells from patients and differentiate …
study. One solution is to derive induced pluripotent stem cells from patients and differentiate …